ReviewFrontiers in artificial intelligence2026
The strategic trajectory of artificial intelligence in Qatar's healthcare sector: a model for UN Sustainable Development Goal 9.
Review in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond the 'Pregnancy Black Box': a global roadmap for artificial intelligence-driven pharmacogenomics in maternal-neonatal health.The pharmacogenomics journal · 2026Review
- The economic imperative of artificial intelligence in maternal and neonatal health: a review of evaluation benefits, frameworks, challenges, future perspectives, and limitations.Cost effectiveness and resource allocation : C/E · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review is first of its kind to strategically position AI and healthcare in the Qatari state under the broad framework of QNV-2030. The review highlights Qatar's forward-looking digital infrastructure upon which its AI initiatives are being built. The paper lists several innovative clinical process developments such as precision medicine and AI-based diagnostics. Furthermore, it analyzes the country's strong ethical and regulatory frameworks underpinning AI adoption, including aspects related to privacy and security. While these aspects are positive, the review identifies areas of concern wherein improvements may be effected: a deeper critical analysis of implementation challenges, greater integration of empirical evidence, and strategies for human capital development beyond mere upskilling. This paper serves as an exemplary case study, demonstrating how a nation can strategically align its top-down initiatives, digital infrastructure investments, and forward-looking regulatory environment with the United Nations Sustainable Development Goal 9 (SDG 9), which focuses on Industry, Innovation, and Infrastructure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.